“Through the guidance of Dr. Joshua Ellenhorn, we will be able to begin our final round of clinical validation trials later this year,” said Royea. “That brings us closer to a launch in Singapore and Asia by mid 2014, with Europe and the US to follow shortly thereafter. With the recent mandate requiring dense breast notification for patients here in the US and an epidemic of breast cancer in Asia, the release of this technology could not be more timely.”
With extensive clinical trials, and years of advanced algorithm refinement completed, FWS' patented intelligent predictive models are projected to improve accuracy for breast cancer assessment to over 75 percent. Unlike mammography and ultrasound which only image tissue characteristics, the FWS system detects tissue alterations down to the cellular level allowing for earlier, safer, more accurate cancer prediction for woman of all ages and tissue types. Ultimately, the FWS system is intended to reduce the number of necessary radiation procedures, while eliminating potentially unnecessary surgeries.
Designed to fit a wearable garment similar to a sports bra, FWS anticipates bringing their technology to market for an affordable price that will make it widely accessible to all markets.
To learn more, visit http://www.firstwarningsystems.com/.
About First Warning Systems Process
Dynamic thermal readings of breast tissue cellular changes creates a
Copyright©2012 Vocus, Inc.
All rights reserved